Cabaletta Bio
Price & Volume
Stats
See more52W Range | $1.76-$26.35 |
Market Cap | $91.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.16 |
News
See moreYahoo Finance • 12 months ago
Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference
Yahoo Finance • last year
Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis
Yahoo Finance • last year
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November
About
CEO | Dr. Steven A. Nichtberger M.D. |
Address | 2929 Arch Street, Philadelphia, PA, United States, 19104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 136 |
